We want to draw your attention to some important resources here in our community as well as understanding some of the signs ...
SALT LAKE CITY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced the publication of a new meta ...
CBT has long been considered a gold-standard treatment for depression—but does it still hold up? A new review of over 60 recent trials suggests its effects remain strong.